RNU6-397P

Across TCGA pan-cancer cohorts, RNU6-397P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-397P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-397P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-397P expression acts as an unfavorable survival marker.

STAD, THYM, and HNSC are the cancer types where RNU6-397P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.075	0.496	.013	27	view →
THYM	DFS	Tertile	All	0.075	0.885	<.001	18	view →
HNSC	OS	Tertile	All	0.149	0.401	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-397P–STAD (OS)

Open the STAD breakdown →